Employment |
Company: Massachusetts General Hospital Cancer Center |
Recipient: You |
Company: Massachusetts Medical Society |
Recipient: You |
|
Leadership |
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests |
Company: hC Bioscience |
Recipient: You |
|
Honoraria |
Company: Medscape |
Recipient: You |
|
Consulting or Advisory Role |
Company: GIMV NV |
Recipient: You |
Company: TigaTx Inc |
Recipient: You |
Company: hC Bioscience |
Recipient: You |
Company: AADi Biosciences |
Recipient: You |
|
Speakers' Bureau |
No Relationships to Disclose |
|
|
Research Funding |
Company: Ascendis Pharma A/S |
Recipient: Your Institution |
Company: Avenge Bio, Inc |
Recipient: Your Institution |
Company: Immunocore Limited |
Recipient: Your Institution |
Company: Duality Biologics |
Recipient: Your Institution |
Company: Merck Sharp & Dohme Corporation |
Recipient: Your Institution |
Company: ProfoundBio |
Recipient: Your Institution |
Company: Compugen |
Recipient: Your Institution |
Company: GOG Foundatioj |
Recipient: Your Institution |
|
Patents, Royalties, Other Intellectual Property |
Please describe: Dr. Yeku has a patent for MUC16 Directed Antibodies for therapeutic applications pending and a patent for Human Artificial Chromosomes for therapeutic applications pending. |
Recipient: You |
|
Expert Testimony |
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses |
Company: ASCO |
Recipient: You |
|
Other Relationship |
No Relationships to Disclose |
|
|
(OPTIONAL) Uncompensated Relationships |
No Relationships to Disclose |
|
|
(OPTIONAL) Open Payments Link |
No Relationships to Disclose |
|
|